Kefir peptides show promise for fracture healing in small study
NCT ID NCT07166458
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a daily supplement made from kefir peptides could help heal broken bones faster in postmenopausal women with osteoporosis. Thirty women with upper arm or wrist fractures were randomly assigned to receive either the kefir supplement or standard care alone. The main goal was to see if the supplement improved bone healing on X-rays after three months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Kefir-derived peptides (dietary supplement)
- What this could lead to
- If it works, this could point toward a simple, natural supplement to help bones heal faster after a fracture.
- What could go wrong
- This is a very small, completed trial with only 30 people. Results may not apply to everyone, and the supplement may not provide significant benefit over standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Apr 2020
- Finished
-
Apr 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Bone mineral density T-score ≤ -2.5 measured by dual-energy X-ray absorptiometry (DXA) 2. Acute fragility fracture of the distal radius or proximal humerus, and 3. Postmenopausal women 4. Age ≥ 50 years Exclusion Criteria: 1. Body mass index (BMI) \> 30 kg/m² 2. Use of medications affecting bone metabolism for more than 4 months, including: glucocorticoids、thyroxine、antiepileptic drugs、bisphosphonates * calcitonin、hormone replacement therapy 3. History of metabolic or systemic diseases affecting bone metabolism, including: hyperparathyroidism、hyperthyroidism、diabetes mellitus、 hepatic cirrhosis、renal insufficiency
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bone fractures are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Chung Hsing University
Taichung, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can better posture strengthen the pelvic floor in osteoporosis?
- Could exercise be the key to stronger bones in women?
- Robotic legs may help rebuild bone in people with spinal cord injury
- Could a simple education program stop the cycle of fractures in the elderly?
- Could cannabis oil be a new key to chronic pain relief and stronger bones in women?
- Could lipedema weaken bones? a new study investigates